• sovaldi-sofosbuvir


Facts of SOVALDI(Sofosbuvir) Tablets ?

  • Medicine Name: SOVALDI
  • Generic Name: SOFOSBUVIR
  • Date of Approval: 6.12.2013
  • Company Name: GILEAD SCIENCES, INC.

Product Description

What is SOVALDI(Sofosbuvir) Tablets ?

SOVALDI is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.

What are the indications and usage?

SOVALDI efficacy has been established in subjects with HCV genotype 1, 2, 3 or 4 infection, including those with hepatocellular carcinoma meeting Milan criteria (awaiting liver transplantation) and those with HCV/HIV-1 co-infection

The following points should be considered when initiating treatment with SOVALDI:

  • Monotherapy of SOVALDI is not recommended for treatment of CHC.
  • Treatment regimen and duration are dependent on both viral genotype and patient population
  • Treatment response varies based on baseline host and viral factors

How supplied/storage and handling ?

SOVALDI tablets are yellow, capsule-shaped, film-coated tablets containing 400 mg sofosbuvir debossed with “GSI” on one side and “7977” on the other side. Each bottle contains 28 tablets (NDC 61958-1501-1), a silica gel desiccant, polyester coil and is closed with a child-resistant closure.


There are no reviews yet.

Be the first to review “Sovaldi”